Komori
Changes in Officers2796Pharmarise Holdings CorporationRetail

Notice Concerning the Executive Structure

The election of 9 directors and 1 statutory auditor was approved at the 40th Annual General Meeting of Shareholders, after which the Board of Directors decided the titles of the chairman, vice chairman, president and other officers, as well as the executive officer structure. There are 3 outside directors, and the executive officers include several individuals who concurrently serve as presidents of subsidiaries.

Worth reading
26Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 28 August 2026
Directors after the change9Number
Shareholders’ meeting approvalElection of 9 directors and 1 statutory auditor at the 40th Annual General Meeting of Shareholders; meeting date: 28 August 2026
Who is moving to which position
ItemDetails
Resolution date28 August 2026
Number of directors after the change9 (including 3 outside directors)
Subject to Approval by the General Meeting of ShareholdersElection of 9 directors and 1 statutory auditor at the 40th Annual General Meeting of Shareholders; meeting date: 28 August 2026
Items this document does not state (18)
Scheduled Appointment DateDate of departureName of appointeeAppointee's new positionAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The election of 9 directors and 1 statutory auditor was approved at the 40th Annual General Meeting of Shareholders held today, and the Board of Directors subsequently decided the titles of directors and other matters.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Executive Structure | Pharmarise Holdings Corporation (2796) timely disclosure | Komori